Cryolife reported $52.17M in Gross Profit on Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US $ 6324M 584M
Atricure ATRC:US $ 63.52M 7.92M
Baxter International BAX:US $ 1457M 107M
Becton, Dickinson and BDX:US $ 2067M 238M
Boston Scientific BSX:US $ 2222M 163M
Cardiovascular Systems CSII:US $ 46.23M 4.8M
Cryolife CRY:US $ 52.17M 1.45M
Edwards Lifesciences EW:US $ 1104.5M 62.6M
Inogen INGN:US $ 46.26M 11.25M
Integra Lifesciences IART:US $ 254.54M 15.94M
Johnson & Johnson JNJ:US $ 16101M 273M
Mesa Laboratories MLAB:US $ 31.34M 3.77M
Natus Medical BABY:US $ 65.41M 7.63M
Pfizer PFE:US $ 19071M 3420M
Resmed RMD:US $ 491.2M 13.12M
Stryker SYK:US $ 2843M 116M
Surmodics SRDX:US $ 19.71M 1.29M
Tandem Diabetes Care TNDM:US $ 101.95M 10.85M
Teleflex TFX:US $ 388.83M 42.6M
Terumo 4543:JP Y 101638M 11138M
Trinity Biotech TRIB:US $ 7.27M 0.03M